Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Lymphoma, Large B-Cell, Diffuse 25Burkitt Lymphoma 15Sarcoma 14Neoplasms 11Lymphoma, Follicular 11Lymphoma 11Hodgkin Disease 10Breast Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Non-Hodgkin 9Triple Negative Breast Neoplasms 8Ovarian Neoplasms 8Endometrial Neoplasms 8Lymphoma, B-Cell 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Recurrence 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Fallopian Tube Neoplasms 5Wilms Tumor 4Osteosarcoma 4Lymphoma, Mantle-Cell 4Liposarcoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Sarcoma, Ewing 3Neuroblastoma 3Lymphoproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Leukemia 3

Interventions

selinexor 1pazopanib 1Zoledronic Acid 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myoepithelioma × Doxorubicin × 90 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡